NOT FOR DISTRIBUTION
Header cover image

Market Cap

€35.5m

Last Updated

2021/05/15 20:47 UTC

Data Sources

Company Financials +

Executive Summary

Nexstim Plc, a neuromodulation company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. More Details


Snowflake Analysis

Limited growth with worrying balance sheet.


Similar Companies

Share Price & News

How has Nexstim's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: NXTMH is more volatile than 90% of Finnish stocks over the past 3 months, typically moving +/- 9% a week.

Volatility Over Time: NXTMH's weekly volatility has decreased from 17% to 9% over the past year, but is still higher than 75% of Finnish stocks.


Market Performance


7 Day Return

-9.3%

NXTMH

-4.9%

FI Medical Equipment

-1.9%

FI Market


1 Year Return

214.7%

NXTMH

20.2%

FI Medical Equipment

39.3%

FI Market

Return vs Industry: NXTMH exceeded the Finnish Medical Equipment industry which returned 20.2% over the past year.

Return vs Market: NXTMH exceeded the Finnish Market which returned 39.3% over the past year.


Shareholder returns

NXTMHIndustryMarket
7 Day-9.3%-4.9%-1.9%
30 Day-23.4%-4.7%1.5%
90 Day-45.2%-5.1%2.7%
1 Year302.0%214.7%21.6%20.2%48.8%39.3%
3 Year-76.6%-99.2%58.3%52.0%32.1%10.7%
5 Year-94.2%-99.8%140.8%123.1%90.7%51.3%

Long-Term Price Volatility Vs. Market

How volatile is Nexstim's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Nexstim undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Nexstim is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Nexstim has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Future Growth

How is Nexstim forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

20.3%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: NXTMH is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: NXTMH is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: NXTMH is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: NXTMH's revenue (27.7% per year) is forecast to grow faster than the Finnish market (3.2% per year).

High Growth Revenue: NXTMH's revenue (27.7% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if NXTMH's Return on Equity is forecast to be high in 3 years time


Past Performance

How has Nexstim performed over the past 5 years?

12.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: NXTMH is currently unprofitable.

Growing Profit Margin: NXTMH is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: NXTMH is unprofitable, but has reduced losses over the past 5 years at a rate of 12.2% per year.

Accelerating Growth: Unable to compare NXTMH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NXTMH is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.1%).


Return on Equity

High ROE: NXTMH's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Financial Health

How is Nexstim's financial position?


Financial Position Analysis

Short Term Liabilities: NXTMH has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: NXTMH has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: NXTMH has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: NXTMH's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: NXTMH has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: NXTMH has less than a year of cash runway if free cash flow continues to grow at historical rates of 12.4% each year.


Dividend

What is Nexstim current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate NXTMH's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NXTMH's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if NXTMH's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NXTMH's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of NXTMH's dividend in 3 years as they are not forecast to pay a notable one for the Finnish market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.3yrs

Average management tenure


CEO

Mikko Karvinen (44 yo)

1.25yrs

Tenure

Mr. Mikko Karvinen, M.Sc. (Econ.), serves as Chief Executive Officer at Nexstim Plc since June 16, 2020 and also served as an Interim Chief Executive Officer at Nexstim Plc since February 11, 2020 until Ju...


Leadership Team

Experienced Management: NXTMH's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Board Members

Experienced Board: NXTMH's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 955%.


Top Shareholders

Company Information

Nexstim Plc's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Nexstim Plc
  • Ticker: NXTMH
  • Exchange: HLSE
  • Founded: 2000
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Market Cap: €35.505m
  • Shares outstanding: 663.64m
  • Website: https://www.nexstim.com

Number of Employees


Location

  • Nexstim Plc
  • Elimäenkatu 9 B
  • Helsinki
  • Uusimaa
  • 510
  • Finland

Listings


Biography

Nexstim Plc, a neuromodulation company, engages in the development and marketing of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally. The company’s...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/15 20:47
End of Day Share Price2021/05/14 00:00
Earnings2020/12/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.